{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:27:38Z","timestamp":1789133258636,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41390-024-03515-7","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T17:03:03Z","timestamp":1724518983000},"page":"1031-1039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and genetic analysis of macrophage activation syndrome complicating juvenile idiopathic inflammatory myopathies"],"prefix":"10.1038","volume":"97","author":[{"given":"Guangzhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"3515_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12016-015-8512-9","volume":"52","author":"I Pagnini","year":"2017","unstructured":"Pagnini, I., Vitale, A., Selmi, C., Cimaz, R. & Cantarini, L. Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms. Clin. Rev. Allergy Immunol. 52, 34\u201344 (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"3515_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pcl.2018.04.006","volume":"65","author":"AM Huber","year":"2018","unstructured":"Huber, A. M. Juvenile idiopathic inflammatory myopathies. Pediatr. Clin. North Am. 65, 739\u2013756 (2018).","journal-title":"Pediatr. Clin. North Am."},{"key":"3515_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/joim.12444","volume":"280","author":"LG Rider","year":"2016","unstructured":"Rider, L. G. & Nistala, K. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J. Intern Med 280, 24\u201338 (2016).","journal-title":"J. Intern Med"},{"key":"3515_CR4","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman, B. M., Rider, L. G., Reed, A. M. & Pachman, L. M. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371, 2201\u20132212 (2008).","journal-title":"Lancet"},{"key":"3515_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-016-0130-4","volume":"15","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia, C., Prencipe, G. & De Benedetti, F. Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr. Rheumatol. Online J. 15, 5 (2017).","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"3515_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40272-019-00367-1","volume":"22","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. & Cron, R. Q. Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management. Paediatr. Drugs 22, 29\u201344 (2020).","journal-title":"Paediatr. Drugs"},{"key":"3515_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00296-019-04442-1","volume":"40","author":"D Poddighe","year":"2020","unstructured":"Poddighe, D. & Dauyey, K. Macrophage activation syndrome in juvenile dermatomyositis: a systematic review. Rheumatol. Int 40, 695\u2013702 (2020).","journal-title":"Rheumatol. Int"},{"key":"3515_CR8","doi-asserted-by":"publisher","first-page":"P220","DOI":"10.1186\/1546-0096-12-S1-P220","volume":"12","author":"Z Gunduz","year":"2014","unstructured":"Gunduz, Z. et al. Macrophage activation syndrome (MAS) in different pediatric rheumatic disease. Pediatr. Rheumatol. 12, P220 (2014).","journal-title":"Pediatr. Rheumatol."},{"key":"3515_CR9","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","volume":"66","author":"KM Kaufman","year":"2014","unstructured":"Kaufman, K. M. et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 66, 3486\u20133495 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"3515_CR10","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1093\/rheumatology\/keab391","volume":"60","author":"X Yang","year":"2021","unstructured":"Yang, X. et al. Unc13d mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome. Rheumatol. (Oxf.) 60, e404\u2013e406 (2021).","journal-title":"Rheumatol. (Oxf.)"},{"key":"3515_CR11","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg, I. E. et al. European League against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 69, 2271\u20132282 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"3515_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter, J. I. et al. Hlh-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48, 124\u2013131 (2007).","journal-title":"Pediatr. Blood Cancer"},{"key":"3515_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli, A. et al. Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 68, 566\u2013576 (2016). 2016.","journal-title":"Arthritis Rheumatol."},{"key":"3515_CR14","unstructured":"Home - SNP - NCBI [Internet]. [cited 19 October 2023]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/"},{"key":"3515_CR15","unstructured":"ClinVar [Internet]. [cited 19 October 2023]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/"},{"key":"3515_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1651-2227.2000.tb00351.x","volume":"89","author":"I Kobayashi","year":"2000","unstructured":"Kobayashi, I. et al. Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatr. 89, 617\u2013619 (2000).","journal-title":"Acta Paediatr."},{"key":"3515_CR17","first-page":"1014","volume":"31","author":"G Sterba","year":"2004","unstructured":"Sterba, G., Rodriguez, C., Sifontes, S. & Vigilanza, P. Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J. Rheumatol. 31, 1014\u20131015 (2004). author reply 1015.","journal-title":"J. Rheumatol."},{"key":"3515_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/03009740510018642","volume":"35","author":"I Kobayashi","year":"2006","unstructured":"Kobayashi, I. et al. Thrombocytopaenia in juvenile dermatomyositis. Scand. J. Rheumatol. 35, 79\u201380 (2006).","journal-title":"Scand. J. Rheumatol."},{"key":"3515_CR19","first-page":"1838","volume":"35","author":"N Yajima","year":"2008","unstructured":"Yajima, N. et al. Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J. Rheumatol. 35, 1838\u20131841 (2008).","journal-title":"J. Rheumatol."},{"key":"3515_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anpedi.2011.12.011","volume":"77","author":"BR Bustos","year":"2012","unstructured":"Bustos, B. R., Carrasco, A. C. & Toledo, R. C. Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis. Pediatr. (Barc.) 77, 47\u201350 (2012).","journal-title":"Pediatr. (Barc.)"},{"key":"3515_CR21","first-page":"4142","volume":"7","author":"Q.H. Wang","year":"2013","unstructured":"Qianhan, W., Qihua, F. & Jiang, C. A case of juvenile dermatomyositis complicated with macrophage activation syndrome. Chin. J. Clin. (Electron. Ed.) 7, 4142\u20134143 (2013).","journal-title":"Chin. J. Clin. (Electron. Ed.)"},{"key":"3515_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3109\/s10165-012-0661-6","volume":"23","author":"H Yamashita","year":"2013","unstructured":"Yamashita, H. et al. Hemophagocytic lymphohistiocytosis complicated by central nervous system lesions in a patient with dermatomyositis: a case presentation and literature review. Mod. Rheumatol. 23, 386\u2013392 (2013).","journal-title":"Mod. Rheumatol."},{"key":"3515_CR23","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","volume":"13","author":"D Poddighe","year":"2014","unstructured":"Poddighe, D., Cavagna, L., Brazzelli, V., Bruni, P. & Marseglia, G. L. A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun. Rev. 13, 1142\u20131148 (2014).","journal-title":"Autoimmun. Rev."},{"key":"3515_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/03009742.2013.863968","volume":"43","author":"V Lilleby","year":"2014","unstructured":"Lilleby, V. et al. Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis. Scand. J. Rheumatol. 43, 171\u2013173 (2014).","journal-title":"Scand. J. Rheumatol."},{"key":"3515_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4274\/jpr.53825","volume":"1","author":"\u015e\u015e \u00d6nen","year":"2014","unstructured":"\u00d6nen, \u015e. \u015e. et al. Juvenile dermatomyositis with a rare and severe complication: macrophage activation syndrome. JPR 1, 218\u2013221 (2014).","journal-title":"JPR"},{"key":"3515_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12969-015-0048-2","volume":"13","author":"H Wakiguchi","year":"2015","unstructured":"Wakiguchi, H. et al. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. Pediatr. Rheumatol. 13, 49 (2015).","journal-title":"Pediatr. Rheumatol."},{"key":"3515_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-016-0986-4","volume":"10","author":"S Teshigawara","year":"2016","unstructured":"Teshigawara, S. et al. Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma: a case report. J. Med. Case Rep. 10, 212 (2016).","journal-title":"J. Med. Case Rep."},{"key":"3515_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/pch\/pxx209","volume":"23","author":"R Deschamps","year":"2018","unstructured":"Deschamps, R., Couture, J., Hadjinicolaou, A. & LeBlanc, C. M. A. A 17-year-old girl with facial edema and weakness. Paediatr. Child Health 23, 241\u2013244 (2018).","journal-title":"Paediatr. Child Health"},{"key":"3515_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/24725625.2020.1832755","volume":"5","author":"C Quintana-Ortega","year":"2021","unstructured":"Quintana-Ortega, C. et al. Fatal outcome of anti-Mda5 juvenile dermatomyositis in a paediatric Covid-19 patient: a case report. Mod. Rheumatol. Case Rep. 5, 101\u2013107 (2021).","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"3515_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/1756-185X.14258","volume":"25","author":"Ng,PLP Chan","year":"2022","unstructured":"Chan, Ng,P. L. P. et al. Janus kinase inhibition in induction treatment of anti-Mda5 juvenile dermatomyositis-associated rapidly progressive interstitial lung disease. Int. J. Rheum. Dis. 25, 228\u2013231 (2022).","journal-title":"Int. J. Rheum. Dis."},{"key":"3515_CR31","first-page":"84","volume":"56","author":"EI Y\u00fcksel","year":"2022","unstructured":"Y\u00fcksel, E. I., Demir, B., G\u00fcrg\u00f6ze, M. K. & \u00c7alik, I. Macrophage activation syndrome due to juvenile amyopathic dermatomyositis with atypical onset. Turkderm Turk. arch. derm. Venereol. 56, 84\u201387 (2022).","journal-title":"Turkderm Turk. arch. derm. Venereol."},{"key":"3515_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12969-022-00675-w","volume":"20","author":"JA Stewart","year":"2022","unstructured":"Stewart, J. A., Price, T., Moser, S., Mullikin, D. & Bryan, A. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-mda5 antibody positive juvenile dermatomyositis: a case report and literature review. Pediatr. Rheumatol. 20, 16 (2022).","journal-title":"Pediatr. Rheumatol."},{"key":"3515_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s13312-022-2606-2","volume":"59","author":"H Jagwani","year":"2022","unstructured":"Jagwani, H., Mondal, A. & Pal, P. Juvenile dermatomyositis with macrophage activation and severe encephalopathy. Indian Pediatr. 59, 725\u2013726 (2022).","journal-title":"Indian Pediatr."},{"key":"3515_CR34","first-page":"rkac067","volume":"6","author":"E Twynam-Perkins","year":"2022","unstructured":"Twynam-Perkins, E. & Martin, N. A case of MDA5-positive Juvenile Dermatomyositis complicated by Macrophage Activation Syndrome. Rheumatol. Adv. Pract. 6, rkac067\u2013012 (2022).","journal-title":"Rheumatol. Adv. Pract."},{"key":"3515_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/mrcr\/rxac086","volume":"7","author":"M Mouri","year":"2023","unstructured":"Mouri, M. et al. Hepatic veno-occlusive disease accompanied by thrombotic microangiopathy developed during treatment of juvenile dermatomyositis and macrophage activation syndrome: a case report. Mod. Rheumatol. Case Rep. 7, 404\u2013409 (2023).","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"3515_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2017.03.033","volume":"377","author":"JP St\u00fcbgen","year":"2017","unstructured":"St\u00fcbgen, J. P. Juvenile dermatomyositis\/polymyositis and lymphoma. J. Neurol. Sci. 377, 19\u201324 (2017).","journal-title":"J. Neurol. Sci."},{"key":"3515_CR37","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens, E. M., Beukelman, T., Paessler, M. & Cron, R. Q. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J. Rheumatol. 34, 1133\u20131138 (2007).","journal-title":"J. Rheumatol."},{"key":"3515_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.55563\/clinexprheumatol\/h0s7tq","volume":"40","author":"K El-Garf","year":"2022","unstructured":"El-Garf, K. et al. A juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian Cohort. Clin. Exp. Rheumatol. 40, 450\u2013456 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"3515_CR39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/BOR.0000000000000549","volume":"30","author":"A Oldroyd","year":"2018","unstructured":"Oldroyd, A. & Chinoy, H. Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 30, 606\u2013613 (2018).","journal-title":"Curr. Opin. Rheumatol."},{"key":"3515_CR40","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono, T. et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 49, 1713\u20131719 (2010).","journal-title":"Rheumatology"},{"key":"3515_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","volume":"160","author":"M Shimizu","year":"2015","unstructured":"Shimizu, M. et al. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clin. Immunol. 160, 277\u2013281 (2015).","journal-title":"Clin. Immunol."},{"key":"3515_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clim.2012.11.004","volume":"146","author":"S Shimizu","year":"2013","unstructured":"Shimizu, S. M. et al. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin. Immunol. 146, 73\u201376 (2013).","journal-title":"Clin. Immunol."},{"key":"3515_CR43","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia, F. et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 66, 3160\u20133169 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"3515_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OARRR.S151013","volume":"10","author":"B Lerkvaleekul","year":"2018","unstructured":"Lerkvaleekul, B. & Vilaiyuk, S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol. 10, 117\u2013128 (2018).","journal-title":"Open Access Rheumatol."},{"key":"3515_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","volume":"49","author":"SJ Vastert","year":"2010","unstructured":"Vastert, S. J. et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology 49, 441\u2013449 (2010).","journal-title":"Rheumatology"},{"key":"3515_CR46","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/art.40438","volume":"70","author":"GS Schulert","year":"2018","unstructured":"Schulert, G. S. et al. Brief report: novel Unc13d intronic variant disrupting an Nf-\u039ab enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 70, 963\u2013970 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"3515_CR47","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2014-11-610816","volume":"125","author":"WA Spessott","year":"2015","unstructured":"Spessott, W. A. et al. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in Stxbp2 that inhibit snare-mediated membrane fusion. Blood 125, 1566\u20131577 (2015).","journal-title":"Blood"},{"key":"3515_CR48","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","volume":"196","author":"M Zhang","year":"2016","unstructured":"Zhang, M. et al. A heterozygous Rab27a mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis. J. Immunol. 196, 2492\u20132503 (2016).","journal-title":"J. Immunol."},{"key":"3515_CR49","first-page":"5249","volume":"14","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. Germline cytotoxic lymphocytes defective mutations in Chinese patients with lymphoma. Oncol. Lett. 14, 5249\u20135256 (2017).","journal-title":"Oncol. Lett."},{"key":"3515_CR50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/jmg.2004.021121","volume":"41","author":"K Yamamoto","year":"2004","unstructured":"Yamamoto, K. et al. Identification of novel Munc13-4 mutations in familial haemophagocytic lymphohistiocytosis and functional analysis of Munc13-4-deficient cytotoxic T lymphocytes. J. Med. Genet. 41, 763\u2013767 (2004).","journal-title":"J. Med. Genet."},{"key":"3515_CR51","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/art.23734","volume":"58","author":"K Zhang","year":"2008","unstructured":"Zhang, K. et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with Munc13-4 polymorphisms. Arthritis Rheum. 58, 2892\u20132896 (2008).","journal-title":"Arthritis Rheum."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03515-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03515-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03515-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:02:39Z","timestamp":1747227759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03515-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3515"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03515-7","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all individual participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}